| Trial | Updated / Type |
Status | Phase | Were Results Reported |
Reported Actual Enrollment |
(MeSH) Terms |
Why Stopped
Limitations And Caveats |
Annotator decisions |
|---|---|---|---|---|---|---|---|---|
| NCT02452385 Details | 2020-01-13 Interventional | 1 | - | Vorolanib Macular Degener… Age-Related Mac… | Sponsor requirements - | |||
| NCT00616122 Details | 2020-01-13 Interventional | 1/2 | 32 | Cyclophosphamid… Methotrexate Sunitinib Breast Neoplasm… Breast Cancer | Risk to benefit ratio not acceptable Based on published literature indicating significant toxicity and low response rate for combination sunitinib in the treatment of advanced breast cancer, the PI and Breast Oncology Site Committee closed enrollment after accrual of 32 participants. | |||
| NCT03210480 2016-001714-14 Details | 2020-01-10 Interventional | 4 | 85 | Lithium Carbona… Bipolar Disorde… | Sponsor's decision due to slow enrollment rate. - | |||
| NCT03181685 Details | 2020-01-10 Interventional | 4 | 60 | Cetrorelix Progesterone Infertility In Vitro Fertil… | 27 couples were recruited. This unexpected poor recruitment was due to more clinical
pregnancies (for a better patients' selection) and more freeze-all cycles. - | |||
| NCT02259491 Details | 2020-01-10 Interventional | 4 | 10 | Calcium Wounds and Inju… Wound Healing | - - | |||
| NCT04115020 Details | 2020-01-09 Interventional | 2 | 0 | Naltrexone Arthritis Arthritis, Psor… Arthritis, Rheu… Chronic Pain Osteoarthritis | A pilot study was negative. - | |||
| NCT04045730 Details | 2020-01-09 Interventional | 2 | 0 | Gemcitabine Paclitaxel Pembrolizumab Adenocarcinoma Pancreas Adenoc… | Halozyme isn't allowing this trial to move forward until their current clinical trial results
are released. - | |||
| NCT04044651 Details | 2020-01-09 Interventional | 2/3 | 0 | Lenvatinib Nivolumab Carcinoma Carcinoma, Hepa… Hepatitis Hepatitis B Hepatocellular … | Bristol-Myers Squibb company terminated this study - | |||
| NCT02010645 Details | 2020-01-02 Interventional | 2 | 6 | Decitabine Leukemia Myelodysplastic… Preleukemia Syndrome | PI Request - | |||
| NCT02697292 Details | 2019-12-30 Interventional | 3 | 17 | Antibodies Immunoglobulins Immunoglobulins… Rho(D) Immune G… gamma-Globulins Epilepsy Autoimmune Epil… | - - | |||
| NCT02628769 2014-003077-42 Details | 2019-12-30 Interventional | 2 | 6 | Solithromycin Lung Diseases Lung Diseases, … Pulmonary Disea… | - Limitations of the trial such as small numbers of subjects analysed or technical problems leading to unreliable data. | |||
| NCT01470742 Details | 2019-12-30 Interventional | 3 | 0 | Capecitabine Stomach Neoplas… Gastric Cancer | We stop because of problems such as insurance. - | |||
| NCT03471351 Details | 2019-12-27 Interventional | 1 | 2 | Pembrolizumab Tenalisib Hodgkin Disease Classical Hodgk… | At this point, the current study in HL does not fit into clinical development and regulatory
strategy. - | |||
| NCT02544152 Details | 2019-12-27 Interventional | 2 | 71 | Lubiprostone Irritable Bowel… Syndrome | - - | |||
| NCT02465528 Details | 2019-12-27 Interventional | 2 | 22 | Ceritinib Glioblastoma Granuloma, Plas… Lymphoma Lymphoma, Large… Neoplasms Anaplastic Larg… Inflammatory My… Tumors With Abe… | - - | |||
| NCT00937768 Details | 2019-12-27 Interventional | 2 | 16 | Goserelin Leuprolide Prostatic Neopl… Prostate Adenoc… Stage IIA Prost… Stage IIB Prost… Stage III Prost… Stage IV Prosta… | - - | |||
| NCT02115048 Details | 2019-12-26 Interventional | 2 | 44 | Afatinib Letrozole Breast Neoplasm… | Study was completed as per amended protocol. Protocol was amended to close enrollment earlier
than initially planned (study continued as per plan). Enrolment was closed prematurely with only 44 participants enrolled compared to what was initially planned (150 participants). Thus, preventing appropriate statistical evaluation (primary/secondary objectives no longer applicable as per protocol). | |||
| NCT03693391 2018-002539-98 Details | 2019-12-19 Interventional | 1 | 22 | Fluorides Healthy | stopped because of a business decision - | |||
| NCT02790957 Details | 2019-12-19 Interventional | 2 | 25 | Plerixafor Chronic Limb-Th… Wounds and Inju… Critical Limb I… Diabetes Wounds | Safety reasons - | |||
| NCT01887691 Details | 2019-12-19 Interventional | 1 | 20 | Eszopiclone Glucose Intoler… Prediabetic Sta… Diabetes Prediabetes Prediabetic | - - |